Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Kristina Masson

Evp - Business Operations at Acrivon Therapeutics, Inc. (ACRV)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $3K

Reported trades

Filed Stock Type Shares Price Value Since
Aug 20SEC ACRVAcrivon Therapeutics, Inc. Sell 1,2292,244,088 held (−0%) $2.01 $2K -18.4%
Aug 20SEC ACRVAcrivon Therapeutics, Inc. Sell 484385,859 held (−0%) $2.01 $973 -18.4%